Evidence map›Paper›PMID 35209048›Full record

ArticleMolecules (Basel, Switzerland)2022

LC-ESI-MS/MS Polyphenolic Profile and In Vitro Study of Cosmetic Potential of

Aleksandra Pieczykolan, Wioleta Pietrzak, Katarzyna Dos Santos Szewczyk, Urszula Gawlik-Dziki, Renata Nowak

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Molecules (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Novel Insights intoMolecules (Basel, Switzerland) · 2024
    Article
  7. Potential for the development ofFrontiers in immunology · 2024
    Article
  8. Plant Extracts as Skin Care and Therapeutic Agents.International journal of molecular sciences · 2023
    Review
  9. Review
  10. Review
  11. Evaluation ofFrontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Aleksandra PieczykolanDepartment of Pharmaceutical Botany, Medical University, 1 Chodźki Street, 20-093 Lublin, Poland.ORCID 0000-0003-4655-4028
Wioleta PietrzakDepartment of Pharmaceutical Botany, Medical University, 1 Chodźki Street, 20-093 Lublin, Poland.ORCID 0000-0002-8129-5837
Katarzyna Dos Santos SzewczykDepartment of Pharmaceutical Botany, Medical University, 1 Chodźki Street, 20-093 Lublin, Poland.ORCID 0000-0003-4884-9110
Urszula Gawlik-DzikiDepartment of Biochemistry and Food Chemistry, University of Life Sciences, 8 Skromna Street, 20-704 Lublin, Poland.ORCID 0000-0002-7308-4335
Renata NowakDepartment of Pharmaceutical Botany, Medical University, 1 Chodźki Street, 20-093 Lublin, Poland.ORCID 0000-0003-4952-3147
Medical University of Lublin · PLUniversity of Life Sciences in Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate the phenolic composition and the biological properties of different

Indexed as

AmaranthaceaeAnti-Inflammatory AgentsCosmeticsEnzyme InhibitorsPlant ExtractsPolyphenolsAnti-Inflammatory AgentsCosmeticsEnzyme InhibitorsPlant ExtractsPolyphenolsAerva extractASEcosmetic potentialLC-ESI-MS/MSMRMORACphenolic compoundspolpalatiliroside

Identifiers

PMID35209048
PMCPMC8879310
OpenAlexW4213243754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.